Organ Transplantation Market is expected to grow with a CAGR of 6.70% due to technological advances

The global organ transplantation market size was worth around USD 18.59 billion in 2023 and is predicted to grow to around USD 33.32 billion by 2032, with a compound annual growth rate (CAGR) of roughly 6.70% between 2024 and 2032.

Organ transplantation is a medical procedure where a damaged or failing organ is removed and replaced with a healthy organ from a donor to save a patient’s life. This medical process includes finding a donor, collecting the organ, preserving it during transport, performing surgery, and giving long-term medicines to prevent organ rejection. Transplant teams include surgeons, doctors, coordinators, nurses, and support staff who manage each stage of the procedure. Patients with kidney failure, liver disease, heart failure, lung disease, and other serious organ conditions receive transplants when other treatments no longer work. The process requires proper tissue matching, blood group matching, appropriate organ size selection, and timely execution for successful results. Advanced storage solutions, surgical techniques, immunosuppressive drugs, and monitoring systems improve transplant success and patient survival rates. Strict laws govern organ donation, patient consent, transplant center approval, and ethical standards to ensure fair treatment and patient safety.

Browse the full “Organ Transplantation Market By Organ Type (Heart Transplant, Kidney Transplant, Pancreas Transplant, Liver Transplant, and Lung Transplant), By Condition (Type 1 Diabetes with Kidney Failure, Heart Failure & Coronary Artery Disease, Liver Cirrhosis & Hepatitis, Chronic Kidney Disease (CKD), and Chronic Obstructive Pulmonary Disease (COPD)), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 - 2032” Report at https://www.zionmarketresearch.com/report/organ-transplantation-market

The growth of the global organ transplantation industry is primarily driven by increasing organ failure prevalence, advancing surgical techniques and immunosuppression therapies, and growing awareness about organ donation.

Market Growth Factors

Several factors are propelling the expansion of the organ transplantation market.

• Chronic disease burden increases: Growing cases of diabetes, high blood pressure, hepatitis, and heart disease cause organ damage, leading to more patients needing organ transplants when medicines no longer control these serious conditions.
• Immunosuppression therapy advances: New anti-rejection medicines with better safety and fewer side effects improve transplant success and patient survival, encouraging doctors to suggest transplants and helping more patients feel confident about surgery.
• Organ preservation technology improvements: Improved storage fluids and machine perfusion systems help keep donor organs healthy for longer periods, allowing more time for transport and surgery and increasing overall transplant success rates.

Restraints

• Organ shortage crisis: Very few donor organs are available compared to long transplant waiting lists, which limits the number of surgeries and causes many patients to lose their lives before receiving a needed organ.
• High procedure costs: Transplant operations involve costly hospital care, expert surgical teams, expensive medicines, and lifelong medical follow-up, which creates financial pressure for patients and healthcare systems worldwide.

Organ Transplantation Market: Report Scope

Market Segmentation

The organ transplantation market can be segmented by organ type, transplant type, therapeutic application, end-user, and region.

Based on organ type, the market is divided into kidney transplants, liver transplants, heart transplants, lung transplants, and pancreas transplants. Kidney transplants are expected to maintain a significant market share during the forecast period due to the high prevalence of end-stage renal disease and kidneys being the most commonly transplanted organ globally.

Based on transplant type, the organ transplantation market is categorized into deceased donor transplants, living donor transplants, domino transplants, and split organ transplants. Deceased-donor transplants are expected to lead the market during the forecast period, given their role as the primary source of most transplanted organs, despite the growth of living-donor programs.

Based on therapeutic application, the market is segregated into immunosuppressive drugs, preservation solutions, tissue typing reagents, surgical instruments, and post-transplant monitoring systems. Immunosuppressive drugs lead the market due to lifelong medication requirements for all transplant recipients to prevent organ rejection and maintain transplant function.

Based on end-user, the organ transplantation industry is classified into transplant centers and hospitals, organ procurement organizations, research institutions, and specialty pharmacies. Transplant centers and hospitals lead the market due to their central role in performing procedures, managing patients, and coordinating the entire transplantation process from evaluation through recovery.

North America leads the global organ transplantation market because the region maintains an advanced healthcare infrastructure with numerous specialized transplant centers staffed by experienced surgical teams. The United States has well-established organ procurement networks coordinating donor identification, organ recovery, and distribution to recipients. Comprehensive insurance coverage often includes transplant procedures, reducing financial barriers for many patients. Strong regulatory frameworks ensure transplant safety, fair organ allocation, and ethical practices. Significant research funding supports innovation in surgical techniques, preservation methods, and immunosuppressive therapies. High rates of chronic diseases create substantial patient populations requiring transplants. Public awareness campaigns promote organ donor registration. Advanced medical technology enables complex multi-organ transplants and experimental procedures. Well-developed pharmaceutical industry supplies immunosuppressive medications and supportive therapies. Academic medical centers conduct clinical trials that advance transplant science and improve patient outcomes.

Key Market Players

Leading companies operating in the global organ transplantation market include:

• Medtronic
• Novartis AG
• BioLife Solutions Inc.
• TransMedics Inc.
• 21st Century Medicine
• AbbVie Inc.
• Teva Pharmaceuticals
• Veloxis Pharmaceuticals
• Zimmer Biomet
• Stryker
• Organ Recovery Systems
• Roche
• Paragonix Technologies
• Arthrex Inc.
• Sanofi

Recent Developments

• In August 2025, Terumo announced the acquisition of OrganOx, a pioneer in organ-preservation technology, aiming to improve transplant access and outcomes worldwide by enhancing organ viability and reducing emergency burdens.
• In November 2025, Stanford Medicine revealed a new machine-learning model predicting donor viability time frames for liver transplants, reducing futile organ procurement by 60% and improving transplant success rates.
• In December 2025, VCU Health Hume‑Lee Transplant Center reported the first fully robotic living-donor liver transplant in the United States, marking a milestone in surgical innovation and patient safety.

The global organ transplantation market is segmented as follows:

By Organ Type

• Heart Transplant
• Kidney Transplant
• Pancreas Transplant
• Liver Transplant
• Lung Transplant

By Condition

• Type 1 Diabetes with Kidney Failure
• Heart Failure & Coronary Artery Disease
• Liver Cirrhosis & Hepatitis
• Chronic Kidney Disease (CKD)
• Chronic Obstructive Pulmonary Disease (COPD)

​By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.co